SuperworthDBV Technologies market cap DBVT
Share price times shares outstanding: what the whole company sells for, since 2018.
- Today, Oct 23, 2026
- $577.3M
- Highest close in our data
- $1.3B
- Apr 2026
DBV Technologies is worth $577.3M at the close on Oct 23, 2026, at $9.75 a share.
That is up 37% over the last year and up 1632% over five years.
Its highest close in our data was $1.3B in Apr 2026.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $577.3M | $535.9M | $1.3B | −11% |
| 2025 | $648.4M | $13M | $769.8M | +5166% |
| 2024 | $12.3M | $9.6M | $23.4M | −33% |
| 2023 | $18.4M | $14.3M | $38.2M | −36% |
| 2022 | $28.8M | $13.3M | $49.6M | +63% |
| 2021 | $17.6M | $17.6M | $71.7M | −29% |
| 2020 | $24.6M | $13.5M | $56.6M | −24% |
| 2019 | $32.6M | $15.6M | $32.6M | +127% |
| 2018 | $14.4M | $14.4M | $61.7M | n/a |
Against its peers
Companies in Biotechnology nearest DBV Technologies' size, closest first, today.
| Company | Market cap |
|---|---|
| DBVTDBV Technologies | $577.3M |
| MGTXMeiraGTx | $884.6M |
| PLXProtalix BioTherapeutics | $205.5M |
| VCELVericel | $2.2B |
| ADMAAdma Biologics | $2.4B |
| Peer median | $1.5B |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on DBV Technologies
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.